AdventHealth Tampa logo
Guidelines
Gram Positive Panel

Gram Positive Panel

Note

Bolded organisms often represent true pathogens when isolated from blood

Gram Positive Panel Antibiotic Selection Guide

Preliminary Result Recommendations

  • Common contaminant
  • Requires clinical assessment to determine if therapy warranted

Preliminary Result Recommendations

  • Common contaminant
  • Requires clinical assessment to determine if therapy warranted

Preliminary Result Recommendations

  • Common contaminant
  • Requires clinical assessment to determine if therapy warranted

No Resistance Markers

  • Preliminary Result Recommendations: Vancomycin pharmacy to dose

Resistance Markers: VanA/B

  • VanA/VanB indicates Vancomycin-resistant enterococci (VRE)
  • Preliminary Result Recommendations: Daptomycin 8mg/kg IV q24h

Preliminary Result Recommendations

  • Potential contaminant
  • If true pathogen, consider Ampicillin 2g IV q4h

Preliminary Result Recommendations

  • Ampicillin 2g IV q4h

Preliminary Result Recommendations

  • Common contaminant
  • Requires clinical assessment to determine if therapy warranted

No Resistance Markers

  • Preliminary Result Recommendations: Cefazolin 2g IV q8h

Resistance Markers: MecA/C

  • MecA/C indicates MRSA
  • Preliminary Result Recommendations: Vancomycin pharmacy to dose (AUC-24)

No Resistance Markers

  • Preliminary Result Recommendations: Common contaminant, requires clinical assessment to determine if therapy warranted

Resistance Markers: MecA/C

  • MecA/C indicates MRSA
  • Preliminary Result Recommendations: Common contaminant, requires clinical assessment to determine if therapy warranted

Preliminary Result Recommendations

  • Common contaminant
  • Requires clinical assessment to determine if therapy warranted

Preliminary Result Recommendations

  • Vancomycin pharmacy to dose

Preliminary Result Recommendations

  • Ceftriaxone 2g IV q24h

Preliminary Result Recommendations

  • Ceftriaxone 2g IV q24h